CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.

Nat Commun

AIDS Research Institute-IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916, Badalona, Spain.

Published: July 2018

CD32 has been shown to be preferentially expressed in latently HIV-1-infected cells in an in vitro model of quiescent CD4 T cells. Here we show that stimulation of CD4+ T cells with IL-2, IL-7, PHA, and anti-CD3/CD28 antibodies induces T-cell proliferation, co-expression of CD32 and the activation of the markers HLA-DR and CD69. HIV-1 infection increases CD32 expression. 79.2% of the CD32+/CD4+ T cells from HIV+ individuals under antiretroviral treatment were HLA-DR+. Resting CD4+ T cells infected in vitro generally results in higher integration of provirus. We observe no difference in provirus integration or replication-competent inducible latent HIV-1 in CD32+ or CD32- CD4+ T cells from HIV+ individuals. Our results demonstrate that CD32 expression is a marker of CD4+ T cell activation in HIV+ individuals and raises questions regarding the immune resting status of CD32+ cells harboring HIV-1 proviruses.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048139PMC
http://dx.doi.org/10.1038/s41467-018-05157-wDOI Listing

Publication Analysis

Top Keywords

cd32 expression
12
cd4+ cells
12
hiv+ individuals
12
cells hiv+
8
cells
7
cd32
5
expression associated
4
associated t-cell
4
t-cell activation
4
activation marker
4

Similar Publications

Dapsone is a sulfone used in treating inflammatory skin conditions. Despite its widespread dermatological use, the pharmacological actions of dapsone remain poorly understood. Here, we examined how different aspects of neutrophil functions are affected by dapsone.

View Article and Find Full Text PDF

HUMAN ALVEOLAR MACROPHAGE FUNCTION IS IMPAIRED IN TUBERCULOSIS CONTACTS WITH DIABETES.

Res Sq

November 2024

DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SA MRC Centre for TB Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Article Synopsis
  • Type 2 diabetes (T2D) increases the risk of tuberculosis (TB), but the reasons for this connection are not fully understood.
  • Research found that alveolar macrophages from T2D patients showed heightened Mycobacterium tuberculosis (M.tb) growth and altered immune responses compared to those without T2D.
  • The study reveals important changes in immune cell functions and gene expression in T2D patients that may explain their increased vulnerability to more severe TB infections.
View Article and Find Full Text PDF

Multiple myeloma is a haematological cancer characterised by the accumulation of clonal plasma cells in the bone marrow and is commonly treated with daratumumab, an anti-CD38 monoclonal antibody immunotherapy. Daratumumab often fails to induce stringent complete responses, due in part to resistance to antibody-dependent cellular cytotoxicity (ADCC) exerted by natural killer (NK)-cells and monocytes. Exercise bouts undertaken by healthy people induce lymphocytosis in blood, including to NK-cells and B-cells, but the effects of exercise are unknown in myeloma patients.

View Article and Find Full Text PDF

The cGAS-STING-interferon regulatory factor 7 pathway regulates neuroinflammation in Parkinson's disease.

Neural Regen Res

August 2025

Laboratory of Neurodegenerative and Neuroinjury Diseases, Wuxi Medicine School, Jiangnan University, Wuxi, Jiangsu Province, China.

Article Synopsis
  • Interferon regulatory factor 7 (IRF7) is significantly increased in a mouse model of Parkinson's disease and is found in microglial cells, highlighting its potential role in the disease's immune response.
  • Inhibiting IRF7 activation reduces the transformation of microglial cells into a neurotoxic form and prevents inflammatory responses associated with Parkinson's disease.
  • Targeting the IRF7 pathway could provide new insights into therapies for Parkinson's disease by modulating inflammatory processes in the brain.
View Article and Find Full Text PDF

Background: Autoimmune diseases (AIDs) are frequently hallmarked by the presence of autoreactive B cell responses which are involved in disease pathogenesis. However, the dynamics of such responses and their relation to clinical disease activity in humans is poorly understood. Rheumatoid arthritis (RA), a prototypic chronic AID, is hallmarked by B cell responses directed against citrullinated proteins.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!